Cargando…
Facile synthesis of multi-faceted, biomimetic and cross-protective nanoparticle-based vaccines for drug-resistant Shigella: a flexible platform technology
BACKGROUND: No commercial vaccines are available against drug-resistant Shigella due to serotype-specific/narrow-range of protection. Nanoparticle-based biomimetic vaccines involving stable, conserved, immunogenic proteins fabricated using facile chemistries can help formulate a translatable cross-p...
Autores principales: | Baruah, Namrata, Ahamad, Nadim, Halder, Prolay, Koley, Hemanta, Katti, Dhirendra S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884485/ https://www.ncbi.nlm.nih.gov/pubmed/36710326 http://dx.doi.org/10.1186/s12951-023-01780-y |
Ejemplares similares
-
An Experimental Adult Zebrafish Model for Shigella Pathogenesis, Transmission, and Vaccine Efficacy Studies
por: Howlader, Debaki R., et al.
Publicado: (2022) -
An attenuated Shigella mutant lacking the RNA-binding protein Hfq provides cross-protection against Shigella strains of broad serotype
por: Mitobe, Jiro, et al.
Publicado: (2017) -
Controlling the bacterial load of Salmonella Typhi in an experimental mouse model by a lytic Salmonella phage STWB21: a phage therapy approach
por: Mondal, Payel, et al.
Publicado: (2023) -
Quercetin, a flavonoid, combats rotavirus infection by deactivating rotavirus-induced pro-survival NF-κB pathway
por: Banerjee, Shreya, et al.
Publicado: (2022) -
Biomimetic Membranes as a Technology Platform: Challenges and Opportunities
por: Hélix-Nielsen, Claus
Publicado: (2018)